Agency Forms Undergoing Paperwork Reduction Act Review, 43202-43203 [2016-15645]
Download as PDF
<![CDATA[
43202
Federal Register / Vol. 81, No. 127 / Friday, July 1, 2016 / Notices
acquisitions. The provision is among the
representations and certifications that
are available for completion in the
System for Award Management (SAM).
B. Annual Reporting Burden
Respondents: 397,000.
Responses per Respondent: 1.46.
Total Responses: 579,620.
Hours per Response: .500.
Total Burden Hours: 289,810.
Frequency: On Occasion.
Affected Public: Businesses or other
for-profit and not-for-profit institutions.
C. Public Comments
Public comments are particularly
invited on: Whether this collection of
information is necessary for the proper
performance of functions of the Federal
Acquisition Regulations (FAR), and
whether it will have practical utility;
whether our estimate of the public
burden of this collection of information
is accurate, and based on valid
assumptions and methodology; ways to
enhance the quality, utility, and clarity
of the information to be collected; and
ways in which we can minimize the
burden of the collection of information
on those who are to respond, through
the use of appropriate technological
collection techniques or other forms of
information technology.
Obtaining Copies of Proposals:
Requesters may obtain a copy of the
information collection documents from
the General Services Administration,
Regulatory Secretariat Division (MVCB),
1800 F Street NW., Washington, DC
20405, telephone 202–501–4755.
Please cite OMB Control No. 9000–
0136 regarding Commercial Item
Acquisitions in all correspondence.
Dated: June 28, 2016.
Mahruba Uddowla,
Acting Director, Federal Acquisition Policy
Division, Office of Governmentwide
Acquisition Policy, Office of Acquisition
Policy, Office of Governmentwide Policy.
Proposed Project
National Amyotrophic Lateral Sclerosis
(ALS) Registry—Revision—Agency for
Toxic Substances and Disease Registry
(ATSDR)
[FR Doc. 2016–15703 Filed 6–30–16; 8:45 am]
BILLING CODE 6820–EP–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
asabaliauskas on DSK3SPTVN1PROD with NOTICES
Agency for Toxic Substances and
Disease Registry
[30Day–16–0041]
Agency Forms Undergoing Paperwork
Reduction Act Review
The Agency for Toxic Substances and
Disease Registry (ATSDR) has submitted
the following information collection
request to the Office of Management and
VerDate Sep<11>2014
19:05 Jun 30, 2016
Jkt 238001
Budget (OMB) for review and approval
in accordance with the Paperwork
Reduction Act of 1995. The notice for
the proposed information collection is
published to obtain comments from the
public and affected agencies.
Written comments and suggestions
from the public and affected agencies
concerning the proposed collection of
information are encouraged. Your
comments should address any of the
following: (a) Evaluate whether the
proposed collection of information is
necessary for the proper performance of
the functions of the agency, including
whether the information will have
practical utility; (b) Evaluate the
accuracy of the agencies estimate of the
burden of the proposed collection of
information, including the validity of
the methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected; (d) Minimize the burden of
the collection of information on those
who are to respond, including through
the use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and (e) Assess information
collection costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570 or
send an email to omb@cdc.gov. Direct
written comments and/or suggestions
regarding the items contained in this
notice to the Attention: CDC Desk
Officer, Office of Management and
Budget, Washington, DC 20503 or by fax
to (202) 395–5806. Written comments
should be received within 30 days of
this notice.
Background and Brief Description
On October 10, 2008, President Bush
signed S. 1382: ALS Registry Act which
amended the Public Health Service Act
to provide for the establishment of an
Amyotrophic Lateral Sclerosis (ALS)
Registry. The activities described are
part of the ongoing effort to maintain the
National ALS Registry.
First approved in 2010 for selfregistration, the primary goal of the
surveillance system/registry remains to
obtain reliable information on the
incidence and prevalence of ALS and to
better describe the demographic
characteristics (age, race, sex, and
PO 00000
Frm 00021
Fmt 4703
Sfmt 4703
geographic location) of persons with
ALS (PALS). Those interested in
participating in the National ALS
Registry must answer a series of
validation questions and if determined
to be eligible they can register.
The secondary goal of the surveillance
system/registry is to collect additional
information on potential risk factors for
ALS, including, but not limited to,
family history of ALS, smoking history,
military service, residential history, lifetime occupational exposure, home
pesticide use, hobbies, hormonal and
reproductive history (women only),
caffeine use, trauma, health insurance,
open-ended supplemental questions,
and clinical signs and symptoms. After
registration, participants complete as
many as 16 voluntary survey modules,
each taking five minutes (maximum 80
minutes). In addition, in Year 1, a
disease progression survey for new
registrants is completed at 0, 3, and 6
months. In Years 2 and 3, the disease
progression survey is repeated at the
yearly anniversary and at 6 months. For
burden estimation, the number of
disease progression survey responses
per year has been rounded up to 3
times.
A biorepository component is being
added to increase the value of the
National ALS Registry to researchers. As
part of registration the participant can
request additional information about the
biorepository and provide additional
contact information. A geographically
representative sample will be selected to
provide specimens. There are two types
of specimen collections, in-home and
postmortem. The in-home collection
includes blood, urine, hair and nails.
The postmortem collection includes the
brain, spinal cord, cerebral spinal fluid
(CSF), bone, muscle, and skin.
In addition to fulfilling the two-part
Congressional mandate, the Registry is
designed to be a tool for ALS
researchers. Now that the Registry has
matured, ATSDR will make data and
specimens available to researchers.
They can request access to specimens,
data, or both collected by the National
ALS Registry for their research projects.
ATSDR will review applications for
scientific validity and human subjects
protection and make data/specimens
available to approved researchers.
ATSDR is also collaborating with ALS
service organizations to conduct
outreach activities through their local
chapters and districts as well as on a
national level. They will provide
ATSDR with information on their
outreach efforts in support of the
Registry on a monthly basis.
There are no costs to the respondents
other than their time. The total number
E:\FR\FM\01JYN1.SGM
01JYN1
43203
Federal Register / Vol. 81, No. 127 / Friday, July 1, 2016 / Notices
of burden hours requested is 1,824
hours.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Type of respondents
Form name
Person with ALS .....................
ALS Case Validation Questions .............................................
ALS Case Registration Form .................................................
Voluntary Survey Modules .....................................................
Disease Progression Survey ..................................................
ALS Biorepository Specimen Processing Form .....................
ALS Registry Research Application Form .............................
Annual Update ........................................................................
Chapter/District Outreach Reporting Form ............................
National Office Outreach Reporting Form .............................
Researchers ............................
ALS Service Organization ......
Jeffrey M. Zirger,
Health Scientist, Acting Chief, Information
Collection Review Office, Office of Scientific
Integrity, Office of the Associate Director for
Science, Office of the Director, Centers for
Disease Control and Prevention.
[FR Doc. 2016–15645 Filed 6–30–16; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–16–0457: Docket No. CDC–206–
0058]
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing efforts to reduce public
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies to take this opportunity to
comment on proposed and/or
continuing information collections, as
required by the Paperwork Reduction
Act of 1995. This notice invites
comment on Aggregate Reports for
Tuberculosis Program Evaluation. The
goal of the study is to allow CDC to
collect and monitor indicators for key
program activities, such as finding
tuberculosis infections in recent
contacts of cases and in other persons
likely to be infected and providing
therapy for latent tuberculosis infection
in an effort to eliminate Tuberculosis in
the United States.
asabaliauskas on DSK3SPTVN1PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
19:05 Jun 30, 2016
Jkt 238001
Written comments must be
received on or before August 30, 2016.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2016–
0058 by any of the following methods:
• Federal eRulemaking Portal:
Regulations.gov. Follow the instructions
for submitting comments.
• Mail: Leroy A. Richardson,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE., MS–
D74, Atlanta, Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. All relevant comments
received will be posted without change
to Regulations.gov, including any
personal information provided. For
access to the docket to read background
documents or comments received, go to
Regulations.gov.
DATES:
Please note: All public comment should be
submitted through the Federal eRulemaking
portal (Regulations.gov) or by U.S. mail to the
address listed above.
To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact the Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE., MS–D74, Atlanta,
Georgia 30329; phone: 404–639–7570;
Email: omb@cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), Federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires Federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
FOR FURTHER INFORMATION CONTACT:
PO 00000
Frm 00022
Fmt 4703
Sfmt 4703
1,670
1,500
750
750
325
36
24
135
2
Number of
responses per
respondent
1
1
1
3
1
1
1
12
12
Average
burden per
response
(in hours)
2/60
10/60
80/60
5/60
30/60
30/60
15/60
5/60
20/60
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology; and (e) estimates of capital
or start-up costs and costs of operation,
maintenance, and purchase of services
to provide information. Burden means
the total time, effort, or financial
resources expended by persons to
generate, maintain, retain, disclose or
provide information to or for a Federal
agency. This includes the time needed
to review instructions; to develop,
acquire, install and utilize technology
and systems for the purpose of
collecting, validating and verifying
information, processing and
maintaining information, and disclosing
and providing information; to train
personnel and to be able to respond to
a collection of information, to search
data sources, to complete and review
the collection of information; and to
transmit or otherwise disclose the
information.
E:\FR\FM\01JYN1.SGM
01JYN1
]]>Agencies
[Federal Register Volume 81, Number 127 (Friday, July 1, 2016)]
[Notices]
[Pages 43202-43203]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-15645]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Agency for Toxic Substances and Disease Registry
[30Day-16-0041]
Agency Forms Undergoing Paperwork Reduction Act Review
The Agency for Toxic Substances and Disease Registry (ATSDR) has
submitted the following information collection request to the Office of
Management and Budget (OMB) for review and approval in accordance with
the Paperwork Reduction Act of 1995. The notice for the proposed
information collection is published to obtain comments from the public
and affected agencies.
Written comments and suggestions from the public and affected
agencies concerning the proposed collection of information are
encouraged. Your comments should address any of the following: (a)
Evaluate whether the proposed collection of information is necessary
for the proper performance of the functions of the agency, including
whether the information will have practical utility; (b) Evaluate the
accuracy of the agencies estimate of the burden of the proposed
collection of information, including the validity of the methodology
and assumptions used; (c) Enhance the quality, utility, and clarity of
the information to be collected; (d) Minimize the burden of the
collection of information on those who are to respond, including
through the use of appropriate automated, electronic, mechanical, or
other technological collection techniques or other forms of information
technology, e.g., permitting electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570 or send an email to omb@cdc.gov. Direct written comments
and/or suggestions regarding the items contained in this notice to the
Attention: CDC Desk Officer, Office of Management and Budget,
Washington, DC 20503 or by fax to (202) 395-5806. Written comments
should be received within 30 days of this notice.
Proposed Project
National Amyotrophic Lateral Sclerosis (ALS) Registry--Revision--Agency
for Toxic Substances and Disease Registry (ATSDR)
Background and Brief Description
On October 10, 2008, President Bush signed S. 1382: ALS Registry
Act which amended the Public Health Service Act to provide for the
establishment of an Amyotrophic Lateral Sclerosis (ALS) Registry. The
activities described are part of the ongoing effort to maintain the
National ALS Registry.
First approved in 2010 for self-registration, the primary goal of
the surveillance system/registry remains to obtain reliable information
on the incidence and prevalence of ALS and to better describe the
demographic characteristics (age, race, sex, and geographic location)
of persons with ALS (PALS). Those interested in participating in the
National ALS Registry must answer a series of validation questions and
if determined to be eligible they can register.
The secondary goal of the surveillance system/registry is to
collect additional information on potential risk factors for ALS,
including, but not limited to, family history of ALS, smoking history,
military service, residential history, life-time occupational exposure,
home pesticide use, hobbies, hormonal and reproductive history (women
only), caffeine use, trauma, health insurance, open-ended supplemental
questions, and clinical signs and symptoms. After registration,
participants complete as many as 16 voluntary survey modules, each
taking five minutes (maximum 80 minutes). In addition, in Year 1, a
disease progression survey for new registrants is completed at 0, 3,
and 6 months. In Years 2 and 3, the disease progression survey is
repeated at the yearly anniversary and at 6 months. For burden
estimation, the number of disease progression survey responses per year
has been rounded up to 3 times.
A biorepository component is being added to increase the value of
the National ALS Registry to researchers. As part of registration the
participant can request additional information about the biorepository
and provide additional contact information. A geographically
representative sample will be selected to provide specimens. There are
two types of specimen collections, in-home and postmortem. The in-home
collection includes blood, urine, hair and nails. The postmortem
collection includes the brain, spinal cord, cerebral spinal fluid
(CSF), bone, muscle, and skin.
In addition to fulfilling the two-part Congressional mandate, the
Registry is designed to be a tool for ALS researchers. Now that the
Registry has matured, ATSDR will make data and specimens available to
researchers. They can request access to specimens, data, or both
collected by the National ALS Registry for their research projects.
ATSDR will review applications for scientific validity and human
subjects protection and make data/specimens available to approved
researchers.
ATSDR is also collaborating with ALS service organizations to
conduct outreach activities through their local chapters and districts
as well as on a national level. They will provide ATSDR with
information on their outreach efforts in support of the Registry on a
monthly basis.
There are no costs to the respondents other than their time. The
total number
[[Page 43203]]
of burden hours requested is 1,824 hours.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average
Number of Number of burden per
Type of respondents Form name respondents responses per response (in
respondent hours)
----------------------------------------------------------------------------------------------------------------
Person with ALS.................... ALS Case Validation 1,670 1 2/60
Questions.
ALS Case Registration Form. 1,500 1 10/60
Voluntary Survey Modules... 750 1 80/60
Disease Progression Survey. 750 3 5/60
ALS Biorepository Specimen 325 1 30/60
Processing Form.
Researchers........................ ALS Registry Research 36 1 30/60
Application Form.
Annual Update.............. 24 1 15/60
ALS Service Organization........... Chapter/District Outreach 135 12 5/60
Reporting Form.
National Office Outreach 2 12 20/60
Reporting Form.
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Health Scientist, Acting Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the Associate Director for
Science, Office of the Director, Centers for Disease Control and
Prevention.
[FR Doc. 2016-15645 Filed 6-30-16; 8:45 am]
BILLING CODE 4163-18-P
